Neuer Glaskörperersatz mit Hydrogel?

Standard

Neuer Glaskörperersatz mit Hydrogel? / Januschowski K, Seuthe AM, Boden KT, Spitzer MS, Szurman P.

in: OPHTHALMOLOGE, Jahrgang 115, Nr. 8, 08.2018, S. 692-696.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

Januschowski K, Seuthe AM, Boden KT, Spitzer MS, Szurman P. 2018, 'Neuer Glaskörperersatz mit Hydrogel?', OPHTHALMOLOGE, Jg. 115, Nr. 8, S. 692-696. https://doi.org/10.1007/s00347-018-0754-5

APA

Januschowski K, Seuthe AM, Boden KT, Spitzer MS, Szurman P. (2018). Neuer Glaskörperersatz mit Hydrogel? OPHTHALMOLOGE, 115(8), 692-696. https://doi.org/10.1007/s00347-018-0754-5

Vancouver

Januschowski K, Seuthe AM, Boden KT, Spitzer MS, Szurman P. Neuer Glaskörperersatz mit Hydrogel? OPHTHALMOLOGE. 2018 Aug;115(8):692-696. https://doi.org/10.1007/s00347-018-0754-5

Bibtex

@article{eb5868bcaa004cc880ccef1350bf4c68,
title = "Neuer Glask{\"o}rperersatz mit Hydrogel?",
abstract = "Although the surgical treatment of rhegmatogenous retinal detachment has advanced, there still is a significant risk of redetachment and a slow visual rehabilitation due to the use of endotamponades. Hydrophobic tamponades act via a buoyancy vector causing an accumulation of proinflammatory cytokines opposite the buoyancy vector. So far, the use of hydrophilic endotamponades is very promising because they represent a possible solution for the abovementioned problems of surgical ablation. This article presents the current developments in this field.",
keywords = "Humans, Hydrogels, Retinal Detachment, Silicone Oils, Visual Acuity, Vitrectomy, Vitreous Body",
author = "{Januschowski K, Seuthe AM, Boden KT, Spitzer MS, Szurman P.}",
year = "2018",
month = aug,
doi = "10.1007/s00347-018-0754-5",
language = "Deutsch",
volume = "115",
pages = "692--696",
journal = "OPHTHALMOLOGE",
issn = "0941-293X",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Neuer Glaskörperersatz mit Hydrogel?

AU - Januschowski K, Seuthe AM, Boden KT, Spitzer MS, Szurman P.

PY - 2018/8

Y1 - 2018/8

N2 - Although the surgical treatment of rhegmatogenous retinal detachment has advanced, there still is a significant risk of redetachment and a slow visual rehabilitation due to the use of endotamponades. Hydrophobic tamponades act via a buoyancy vector causing an accumulation of proinflammatory cytokines opposite the buoyancy vector. So far, the use of hydrophilic endotamponades is very promising because they represent a possible solution for the abovementioned problems of surgical ablation. This article presents the current developments in this field.

AB - Although the surgical treatment of rhegmatogenous retinal detachment has advanced, there still is a significant risk of redetachment and a slow visual rehabilitation due to the use of endotamponades. Hydrophobic tamponades act via a buoyancy vector causing an accumulation of proinflammatory cytokines opposite the buoyancy vector. So far, the use of hydrophilic endotamponades is very promising because they represent a possible solution for the abovementioned problems of surgical ablation. This article presents the current developments in this field.

KW - Humans

KW - Hydrogels

KW - Retinal Detachment

KW - Silicone Oils

KW - Visual Acuity

KW - Vitrectomy

KW - Vitreous Body

U2 - 10.1007/s00347-018-0754-5

DO - 10.1007/s00347-018-0754-5

M3 - SCORING: Review

C2 - 29959511

VL - 115

SP - 692

EP - 696

JO - OPHTHALMOLOGE

JF - OPHTHALMOLOGE

SN - 0941-293X

IS - 8

ER -